News

September 22, 2025
PRNewswire
Artificial Intelligence, Networking, News, Uncategorized

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

A leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a...

The-Challenge-of-Strategy-Implementation

September 22, 2025
PRNewswire
Artificial Intelligence, Cloud

New Survey: One in Four Companies Lose More Than $1 Million Annually at Online Checkout

August 2025 reveals that while 83% of U.S. executives believe that by 2027, most payments will be initiated, optimized, or completed by artificial intelligence (AI), one in four report losing...

September 18, 2025
PRNewswire
Biotechnology, Healthcare, News

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (Alnylam) as a member of the Alliance for Genomic Discovery (AGD). Alnylam, a pioneer in RNA interference (RNAi)...

September 18, 2025
PRNewswire
Artificial Intelligence, News

Global Drone Mapping Market is a Rapidly Expanding Sector Expected to Reach $6.7 Billion By 2035

Governments and companies alike are increasingly opting for drones for real-time decision-making, land surveying & evaluation, mapping and preventive maintenance. The market is set to continue its rapid growth...

September 18, 2025
PRNewswire
Artificial Intelligence, Networking, News

Relativity Networks Partners with Network Planning Solutions to Accelerate Hollow-Core Fiber Deployments

Relativity Networks, the leading at-scale provider of next-generation fiber-optic technology, has entered into a strategic partnership with Network Planning Solutions (NPS), to support commercial deployments of hollow-core fiber (HCF) infrastructure. Relativity...

Miri-Technologies-Provides-Free-Internet-

September 18, 2025
PRNewswire
Artificial Intelligence, Networking, News

Hydrolix Adds Quesma Gateway Proxy IP to Its Portfolio, Assuring Continued Kibana Support

Hydrolix, the company optimizing the economics and performance of log-driven observability and edge security through its streaming data lake platform, today announced it has purchased intellectual property from Quesma to continue...

Why-B2B-Businesses-Need-to-Focus-on-Customer-Experience

September 18, 2025
PRNewswire
Business Broadcast, Networking, News

WiMi Researches a Quantum Machine Learning Framework for Enhanced Privacy Protection

WiMi Hologram Cloud Inc. (NASDAQ: WiMi) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that they are committed to developing a hybrid quantum-classical...

VR Vision Launches "The Intelligent Training Era"

September 17, 2025
PRNewswire
Artificial Intelligence, Networking, News

IntelePeer Appoints Nancy Scott Chief Marketing Officer

IntelePeer, the only end-to-end conversational AI platform provider, is pleased to announce the appointment of Nancy Scott to the position of Chief Marketing Officer (CMO). An accomplished, tech-savvy communications...

September 17, 2025
PRNewswire
Artificial Intelligence, Cloud, News

90% of Enterprises Actively Adopting AI Agents, Study Finds

Kong Inc., a leading developer of cloud API and AI technologies, today released findings from its latest research report, which explores how businesses are preparing to integrate autonomous AI...

September 17, 2025
PRNewswire
Biotechnology, Healthcare, News

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, and Berlin-based femtech startup Frieda Health have announced the successful completion of their clinical trial for a...